Health status and hypoglycaemia with insulin degludec versus insulin glargine: a 2-year trial in insulin-naïve patients with type 2 diabetes

Insulin degludec (IDeg) is a new basal insulin with an ultra-long and stable glucose-lowering effect. We compared once-daily IDeg and insulin glargine (IGlar), both in combination with metformin ± dipeptidyl peptidase-4 inhibitors, in a 52-week, open-label, treat-to-target trial in patients with typ...

全面介紹

Na minha lista:
書目詳細資料
發表在:Diabetes Obes Metab
Main Authors: Rodbard, H W, Cariou, B, Zinman, B, Handelsman, Y, Wolden, M L, Rana, A, Mathieu, C
格式: Artigo
語言:Inglês
出版: Blackwell Publishing Ltd 2014
主題:
Research Letters
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4237540/
https://ncbi.nlm.nih.gov/pubmed/24495158
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.12271
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍